FUBIMINA is primarily used in research settings, particularly in the study of cannabinoid receptors and their interactions. It acts as a potent agonist for the CB1 receptor, making it valuable for investigating the endocannabinoid system and its role in various physiological processes. Researchers utilize it to explore potential therapeutic applications, such as pain management, neuroprotection, and appetite regulation. Additionally, its structural and functional properties help in understanding the binding mechanisms of cannabinoid receptors, aiding in the development of new pharmacological compounds. Its use is strictly limited to laboratory environments due to its potent psychoactive effects and lack of approval for medical or recreational use.